Critical Illness

Critical Illness provides evidence-based information to help guide the most effective treatment for adult patients in intensive care.


  • Make informed and objective decisions under time pressure
  • Effectively manage complex patient treatment options, including dose adjustments for those on renal replacement therapies and ECMO
  • Increase patient safety


Sign up to be notified when the full set of Critical Illness guidance is available to purchase in 2021.


If you would like to be involved in the further development of Critical Illness by sharing your expertise and suggestions, please let us know by checking the appropriate box, and we will be in contact later this year.

We collect and process data in accordance with our Privacy Policy

Essential medicines information to support complex decision-making in critical care 

Sign up to be notified when the full set of 

Critical Illness guidance is available to purchase in 2021

© The Royal Pharmaceutical Society 2020. All Rights Reserved.  

RPS is a company incorporated in England Under Royal Charter. Company Number RC000799. 66-68 East Smithfield, London, E1W 1AW, UK